Daniel E. Geffken - Aug 23, 2023 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role: Director
Signature: /s/ Jamie McAndrew, as Attorney-in-Fact
Stock symbol: WINT
Transactions as of: Aug 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/29/2023, 05:37 PM
Previous filing: May 3, 2023
Next filing: Oct 30, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WINT	Common Stock	Award	$0	+2.03K	+1431.69%	$0.00	2.18K	Aug 23, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WINT	Stock Option (Right to Buy)	Award	$0	+3.05K		$0.00	3.05K	Aug 23, 2023	Common Stock	3.05K	$1.21	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.
F2	Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023.
F3	The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.